ArticleAging and disease2025
Early Risk Prediction Model for Stroke-Heart Syndrome Following Endovascular Therapy.
Article in Aging and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neurocardiology: Brain-Heart Interactions in the Heart.MedComm · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stroke-heart syndrome (SHS) significantly impacts patient prognosis, and reperfusion treatment strategies may have an impact on the occurrence of SHS following acute ischemic stroke (AIS). This study aimed to develop a nomogram-based SHS prediction model for anterior circulation stroke patients after endovascular therapy (EVT), addressing the current gap in early risk stratification of this population. This retrospective study enrolled 218 AIS patients who underwent EVT between January 2013 and June 2021, with an observed SHS incidence of 13.8% within the first two weeks post-EVT. We used the least absolute shrinkage and selection operator regression and multivariate logistic regression analysis to identify variables strongly associated with SHS. The results showed that age (OR 1.060, 95% CI 1.021-1.100, P = 0.002), hyperlipidemia (OR 3.400, 95% CI 1.289-8.968, P = 0.013), creatinine (OR 1.023, 95% CI 1.000-1.046, P = 0.049), and total anterior circulation infarct (TACI, OR 4.875, 95% CI 1.984-11.980, P = 0.001) were significantly associated with SHS and were subsequently incorporated into the construction of a nomogram-based prediction model. The area under receiver-operating characteristic curve (AUC), calibration curve, Hosmer-Lemeshow test, and Brier score were employed to comprehensively assess the accuracy and calibration of this model. The results demonstrate that the model exhibits good discriminatory ability (AUC = 0.812), calibration (Hosmer-Lemeshow test P = 0.855, Brier score = 0.098), and robustness (internal cross-validation AUC = 0.811). Furthermore, we assessed neurological outcomes at 3 months post-stroke using the modified Rankin Scale and found that SHS was independently associated with an increased risk of unfavorable functional outcome (OR 3.267, 95% CI 1.159-9.212, P = 0.025). In conclusion, SHS significantly increases the risk of unfavorable outcomes in AIS patients undergoing EVT. The nomogram, incorporating age, hyperlipidemia, TACI, and creatinine, exhibits strong predictive accuracy for early SHS; nevertheless, multicenter prospective validation is warranted prior to clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.